LUCAT1在缺氧胶质瘤干细胞中调控DNA损伤应答
该研究探讨缺氧条件下胶质瘤干细胞中lncRNA LUCAT1对DNA损伤应答的调控机制。研究发现LUCAT1直接结合DNA-PK全酶并调控非同源末端连接,同时影响BRCA1和RAD51;敲低LUCAT1可增加DNA损伤、增敏DDR抑制剂并改善放疗小鼠生存。
要点
- LUCAT1在缺氧胶质瘤干细胞中直接结合DNA-PK全酶并调控NHEJ通路。
- 敲低LUCAT1增加DNA损伤并增敏PARP或DNA-PK抑制剂及放疗。
- LUCAT1是增强胶质母细胞瘤DDR抑制剂和放疗疗效的潜在靶点。
核心结论
- LUCAT1是缺氧胶质瘤干细胞中关键的DNA损伤应答调控因子,也是增强胶质母细胞瘤DDR抑制剂和放疗疗效的有前景靶点。
研究设计与样本
- 研究采用iDRIP和质谱鉴定缺氧胶质瘤干细胞中LUCAT1互作蛋白,并用RNA pulldown和RNA免疫沉淀确认互作。
- 机制研究涉及免疫沉淀、邻近连接 assay、彗星 assay、免疫染色及shRNA敲低LUCAT1。
- 基因表达变化通过胶质瘤干细胞RNAseq和TCGA数据集评估。
- 功能实验在胶质瘤干细胞和原位异种移植中进行,采用LUCAT1单独敲低或联合PARP抑制、DNA-PK抑制或放疗。
主要发现
- LUCAT1直接与DNA-PK全酶互作,调控其在非同源末端连接通路中的组装和功能。
- LUCAT1还调控同源重组关键蛋白BRCA1和RAD51。
- 敲低LUCAT1增加DNA损伤,使胶质瘤干细胞对DDR抑制剂增敏。
- 敲低LUCAT1改善接受放疗小鼠的生存。
临床怎么用
- LUCAT1可作为胶质母细胞瘤中增强DDR抑制剂和放疗疗效的潜在联合靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genomic stability is essential for cell survival, particularly under stress conditions like hypoxia, which disrupt DNA repair. Glioblastoma (GBM) is markedly resistant to DNA-damaging therapies, primarily due to glioma stem cells (GSCs) and the hypoxic tumor microenvironment. Long non-coding RNAs (lncRNAs) play a significant role in maintaining genome integrity, but their involvement in the DNA damage response (DDR) under hypoxic conditions in GSCs remains unclear. We previously identified LUCAT1 as the most highly induced lncRNA in GSCs under hypoxia and a key regulator HIF1α activity. We now investigate its role in DDR regulation. METHODS: LUCAT1-interacting proteins in GSCs under hypoxia were identified using identification of direct RNA interacting proteins (iDRIP) and mass spectrometry. Interactions were confirmed by RNA pulldown and RNA -immunoprecipitation. Mechanistic studies involved immunoprecipitation, proximity ligation assays, comet assays, immunostaining, and LUCAT1 knockdown using shRNA. Gene expression changes were evaluated via RNAseq in GSCs and TCGA datasets. Functional assays were conducted in GSCs and orthotopic xenografts with LUCAT1 depletion alone or in combination with PARP or DNA-PK inhibition or radiation. RESULTS: LUCAT1 directly interacts with the DNA-PK holoenzyme, modulating its assembly and function in the non-homologous end joining (NHEJ) pathway. It also regulates BRCA1 and RAD51, key proteins in homologous recombination (HR). Depletion of LUCAT1 increased DNA damage, sensitized GSCs to DDR inhibitors, and improved survival in mice treated with radiotherapy. CONCLUSIONS: LUCAT1 is a critical DDR regulator in GSCs under hypoxia and a promising target to enhance the -efficacy of DDR inhibitors and radiotherapy in GBM.
引用
- Huang H, Shah H, Dashora H, et al. lncRNA LUCAT1 regulates DNA damage response in glioma stem cells under hypoxia. Neuro Oncol. 2026. PMID: 41619782. doi:10.1093/neuonc/noag017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。